{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:07Z","timestamp":1790743867868,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.berh.2017.12.003","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T22:21:43Z","timestamp":1515536503000},"page":"535-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Juvenile dermatomyositis: Latest advances"],"prefix":"10.1016","volume":"31","author":[{"given":"Qiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2017.12.003_bib2","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.38137","article-title":"Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders","volume":"65","author":"Miller","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","article-title":"Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment","volume":"23","author":"Wedderburn","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/joim.12444","article-title":"The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes","volume":"280","author":"Rider","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.berh.2017.12.003_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"11","key":"10.1016\/j.berh.2017.12.003_bib6","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40272-017-0240-6","article-title":"Treatment of juvenile dermatomyositis","volume":"19","author":"Papadopoulou","year":"2017","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/annrheumdis-2013-203396","article-title":"Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease","volume":"74","author":"Varsani","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis","volume":"60","author":"L\u00f3pez De Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2017.12.003_bib11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/art.22993","article-title":"Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients","volume":"57","author":"Miles","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","article-title":"Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset","volume":"47","author":"Manlhiot","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.39466","article-title":"Brief report: association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis","volume":"68","author":"Habers","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2017.12.003_bib14","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3899\/jrheum.160688","article-title":"Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash","volume":"44","author":"Huber","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-016-0134-0","article-title":"Childhood Arthritis and Rheumatology Research Alliance Consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease","volume":"15","author":"Kim","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12969-017-0174-0","article-title":"Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America","volume":"15","author":"Spencer","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"10.1016\/j.berh.2017.12.003_bib21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis (JDM) across North America: the childhood arthritis and rheumatology research alliance (CARRA) JDM treatment survey","volume":"37","author":"Stringer","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl. 10","key":"10.1016\/j.berh.2017.12.003_bib22","article-title":"Analysis of efficacy and safety of cyclophosphamide in juvenile dermatomyositis using a large national UK cohort","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2017.12.003_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1546-0096-9-S1-P57","article-title":"Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland","author":"Martin","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib24","first-page":"117","article-title":"Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis","volume":"29","author":"Guseinova","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"10019","key":"10.1016\/j.berh.2017.12.003_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib26","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/kew396","article-title":"Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab","volume":"56","author":"Aggarwal","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 10","key":"10.1016\/j.berh.2017.12.003_bib29","article-title":"Efficacy and safety of tumour necrosis factor antagonists in a large cohort of juvenile dermatomyositis patients","volume":"68","author":"Campanilho-Marques","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/acr.22198","article-title":"Pilot study of etanercept in patients with refractory juvenile dermatomyositis","volume":"66","author":"Rouster-Stevens","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2017.12.003_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1546-0096-12-24","article-title":"A\u00a0survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America","volume":"12","author":"Soybilgic","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.berh.2017.12.003_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/acr.21684","article-title":"Exercise training in juvenile dermatomyositis","volume":"64","author":"Omori","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mus.23484","article-title":"Near-infrared spectroscopy during exercise and recovery in children with juvenile dermatomyositis","volume":"47","author":"Habers","year":"2013","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3899\/jrheum.160997","article-title":"Submaximal exercise capacity in juvenile dermatomyositis after longterm disease: the contribution of muscle, lung, and heart involvement","volume":"44","author":"Berntsen","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.21332","article-title":"Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis","volume":"53","author":"Maillard","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2017.12.003_bib37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/rheumatology\/kew026","article-title":"Muscles in motion: a randomized controlled trial on the feasibility, safety and efficacy of an exercise training programme in children and adolescents with juvenile dermatomyositis","volume":"55","author":"Habers","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2017.12.003_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/1742395317690034","article-title":"The family impact of caring for a child with juvenile dermatomyositis","author":"Kountz-Edwards","year":"2017","journal-title":"Chron Illness"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ije\/1.3.271","article-title":"Chronic illness, family functioning, and psychological adjustment: a model for the allocation of preventive mental health services","volume":"1","author":"Pless","year":"1972","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/adc.2003.041541","article-title":"Adverse psychological effects of corticosteroids in children and adolescents","volume":"90","author":"Stuart","year":"2005","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2017.12.003_bib42","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.berh.2017.12.003_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib45","first-page":"1031","article-title":"A\u00a0Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases","volume":"27","author":"Sato","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2017.12.003_bib46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"Sanner","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.berh.2017.12.003_bib47","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00296-005-0030-2","article-title":"Twelve years experience of juvenile dermatomyositis in North India","volume":"26","author":"Singh","year":"2006","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","article-title":"Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes","volume":"133","author":"Arioglu","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/ket380","article-title":"Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients","volume":"53","author":"Mathiesen","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib52","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","article-title":"Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study","volume":"16","author":"Tansley","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/s10165-007-0610-y","article-title":"Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease","volume":"17","author":"Morinishi","year":"2007","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2017.12.003_bib54","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ppul.22742","article-title":"The lung is involved in juvenile dermatomyositis","volume":"48","author":"Pouessel","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.berh.2017.12.003_bib56","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/annrheumdis-2013-203279","article-title":"In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity","volume":"73","author":"Schwartz","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib57","doi-asserted-by":"crossref","first-page":"e000291","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pcad.2012.09.001","article-title":"Heart rate variability today","volume":"55","author":"Xhyheri","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1525-1470.1985.tb00465.x","article-title":"Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases","volume":"2","author":"Taieb","year":"1985","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/ard.57.3.172","article-title":"Fatal vascular occlusion in juvenile dermatomyositis","volume":"57","author":"Takeda","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02386727","article-title":"Duodenal perforation in childhood dermatomyositis","volume":"14","author":"Magill","year":"1984","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib62","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.22782","article-title":"Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy","volume":"57","author":"Mamyrova","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib63","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.22433","article-title":"RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis","volume":"56","author":"Rouster-Stevens","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2017.12.003_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0100-879X2005000200020","article-title":"Bone mineral density of Brazilian girls with juvenile dermatomyositis","volume":"38","author":"Castro","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib65","first-page":"571","article-title":"Menstrual and hormonal alterations in juvenile dermatomyositis","volume":"28","author":"Aikawa","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2017.12.003_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3476(64)80325-5","article-title":"Dermatomyositis","volume":"64","author":"Bitnum","year":"1964","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib67","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/acr.22212","article-title":"Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies","volume":"66","author":"Huber","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.berh.2017.12.003_bib68","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib69","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","article-title":"Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis","volume":"160","author":"Arabshahi","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.berh.2017.12.003_bib70","first-page":"1644","article-title":"Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops","volume":"31","author":"Smith","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib71","first-page":"722","article-title":"Nailfold capillaroscopy in children and adolescents with rheumatic diseases","volume":"52","author":"Piotto","year":"2012","journal-title":"Rev Bras Reumatol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib72","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis","volume":"50","author":"Schmeling","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.berh.2017.12.003_bib73","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1002\/art.34659","article-title":"Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2017.12.003_bib74","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/ker262","article-title":"Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system","volume":"50","author":"Davis","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2017.12.003_bib75","doi-asserted-by":"crossref","first-page":"715352","DOI":"10.1155\/2013\/715352","article-title":"Disease activity measures in paediatric rheumatic diseases","volume":"2013","author":"Luca","year":"2013","journal-title":"Int J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib76","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/annrheumdis-2017-211401","volume":"76","author":"Rider","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 11","key":"10.1016\/j.berh.2017.12.003_bib77","first-page":"S118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.berh.2017.12.003_bib78","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/acr.22041","article-title":"Lack of achievement of a full score on the childhood myositis assessment scale by healthy four-year-olds and those recovering from juvenile dermatomyositis","volume":"65","author":"Qui\u00f1ones","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.20397","article-title":"Normal scores for nine maneuvers of the childhood myositis assessment scale","volume":"51","author":"Rennebohm","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.berh.2017.12.003_bib81","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.23313","article-title":"Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats","volume":"59","author":"Huber","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2017.12.003_bib82","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/acr.22867","article-title":"Comparison of the utility and validity of three scoring tools to measure skin involvement in patients with juvenile dermatomyositis","volume":"68","author":"Campanilho-Marques","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.berh.2017.12.003_bib83","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/bjd.15596","article-title":"Evaluation of the reliability of the cutaneous dermatomyositis disease area and severity index and the cutaneous assessment tool-binary method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists","volume":"177","author":"Tiao","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.berh.2017.12.003_bib84","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/art.1780401109","article-title":"Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group","volume":"40","author":"Rider","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib85","first-page":"1106","article-title":"Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies. Juvenile dermatomyositis disease activity collaborative study group","volume":"28","author":"Huber","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2017.12.003_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1546-0096-11-S2-P25","article-title":"Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report","author":"Varnier","year":"2013","journal-title":"Pediatr Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2017.12.003_bib87","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"Lazarevic","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2017.12.003_bib88","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.39200","article-title":"Analysis of published criteria for clinically inactive disease in a large juvenile dermatomyositis cohort shows that skin disease is underestimated","volume":"67","author":"Almeida","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2017.12.003_bib89","article-title":"The development of a consensus dataset in Juvenile Dermatomyositis for clinical use to inform research","author":"McCann","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib90","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.bor.0000434667.55020.e1","article-title":"Registries in idiopathic inflammatory myopathies","volume":"25","author":"Lundberg","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2017.12.003_bib91","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/BOR.0000000000000119","article-title":"Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research","volume":"26","author":"Rider","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"Martin","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2017.12.003_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2017.12.003_bib94","article-title":"Modelling disease activity in juvenile dermatomyositis: a Bayesian approach","author":"van Dijkhuizen","year":"2017","journal-title":"Stat Meth Med Res"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169421730102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169421730102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:18:37Z","timestamp":1761499117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169421730102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S152169421730102X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2017.12.003","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile dermatomyositis: Latest advances","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}